Arena Pharma Upgraded Ahead Of Clinical Data Release
January 03, 2018 at 16:47 PM EST
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) received an upgrade from Wall Street on Wednesday as it awaits Phase 2 data for the S1P ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|